What exactly are multimodal AI agents, and why do they matter for research?
Multimodal AI agents are systems that combine large language models (LLMs) with the ability to perceive and act across different types of data—text, images, audio, sensor readings—and to use external tools like databases or software interfaces. Unlike earlier AI that passively answered questions, these agents set goals, maintain memory across interactions, retrieve knowledge on demand, and even navigate clinical software [3]. This matters because it moves AI from a one-shot question-answer tool to a persistent, context-aware collaborator that can handle complex, real-world tasks. For example, in radiology, agentic systems can autonomously coordinate the entire workflow—from optimizing scan protocols to analyzing images and generating preliminary reports—by chaining together specialized models and tools [3].
Where do the studies agree on the impact of these agents?
A second point of agreement is that these systems require careful human oversight and ethical safeguards. [2] emphasizes that clinicians must remain in control, and that ethical, patient-centered AI demands close technical-clinical collaboration. [3] echoes this, warning that probabilistic models must be managed within deterministic clinical workflows, and that a structured four-phase implementation roadmap—from low-risk automation to full workflow orchestration—is necessary to maintain safety. [1] also identifies major challenges in human-AI interaction and system architecture that remain unresolved. So while the potential is large, all three papers caution that deployment must be gradual and supervised.
Where do the studies disagree or leave open questions?
The papers do not directly conflict, but they emphasize different aspects of the challenge, which reveals gaps in the evidence. [1] takes the broadest view, linking industry deep research to academic AI for Science (AI4S) and arguing that AI and science can mutually reinforce each other (Science for AI, or S4AI). [2] and [3] focus on specific medical domains—Alzheimer's and radiology—and are more cautious about near-term deployment. For instance, [2] highlights that current AI tools are 'narrowly focused, unimodal, and lack longitudinal reasoning or interpretability,' implying that the shift to agentic systems is still aspirational. [3] is more concrete about technical capabilities (e.g., multiagent coordination outperforming single agents) but also flags unresolved issues like economic sustainability, cybersecurity, and bias mitigation. The key open question is whether the impressive demonstrations in controlled settings will translate to robust, safe performance in messy real-world environments—none of the papers provide large-scale, real-world deployment data to answer that yet.
About These Sources
This answer is built on 3 peer-reviewed studies — published in 2026, 3 from 2024 or later — selected as the most relevant from 3 studies that passed quality screening, drawn from 39 papers retrieved from a database of over 500 million.
Sources used in this answer
Deep Research of Deep Research: From Transformer to Agent, From AI to AI for Science
This 2026 review paper positions LLMs and Stable Diffusion as the twin pillars of generative AI and lays out a roadmap from transformers to agents, arguing that deep research represents a prototypical vertical application for general-purpose agents aimed at reaching or surpassing top human scientists.
AI agents in Alzheimer's disease management: challenges and future directions.
This perspective paper on Alzheimer's disease argues that current AI tools are narrowly focused and unimodal, and that agentic AI—by integrating imaging, genomics, cognitive, and behavioral data—can track disease progression, identify therapeutic targets, and support clinical decision-making while keeping clinicians in control.
Agentic AI in Radiology: Evolution from Large Language Models to Future Clinical Integration.
This paper on radiology demonstrates that multiagent systems using hierarchical, collaborative, or sequential coordination patterns outperform single-agent approaches, and can autonomously coordinate entire clinical workflows from preacquisition protocol optimization to preliminary report generation, though it cautions that successful deployment requires managing probabilistic models within deterministic workflows.